Sheikh, Mudnia

Sheikh, Mudnia was paid $332K by Medicaid between Feb 2018 and Oct 2023, across 85 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 29% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in New York

Rank by total paid#26 of 94

Median peer was paid$46K

This provider vs. median7.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,142	$9K
2019	663	$4K
2020	5,299	$117K
2021	8,832	$106K
2022	5,514	$51K
2023	4,466	$45K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	29%	2,157	1,788	$96K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	7.5%	1,541	1,524	$25K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	6.9%	118	103	$23K
80050	General health panel	5.3%	823	822	$18K
86769		4.2%	554	546	$14K
80061	Lipid panel	3.6%	1,607	1,596	$12K
82607		3.5%	1,363	1,350	$12K
84481		3.1%	1,067	1,061	$10K
82746		3.0%	1,211	1,201	$10K
83036	Hemoglobin; glycosylated (A1C)	2.2%	1,393	1,374	$7K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.2%	653	594	$7K
82728		2.0%	886	879	$7K

73 more codes

88305	Level IV - Surgical pathology, gross and microscopic examination	2.0%	140	$7K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.0%	152	$7K
84439		1.9%	1,213	$6K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.4%	115	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.4%	246	$5K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.4%	246	$5K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.4%	1,030	$5K
80053	Comprehensive metabolic panel	1.2%	768	$4K
87581		1.1%	216	$4K
87486		1.1%	215	$4K
83550		<1%	698	$3K
83540		<1%	825	$3K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	91	$3K
83735		<1%	630	$2K
86480		<1%	55	$2K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	49	$2K
86704		<1%	285	$2K
86706		<1%	302	$2K
88312		<1%	57	$2K
81001		<1%	859	$2K
86708		<1%	222	$1K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	120	$1K
83516		<1%	87	$1K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	16	$1K
88313		<1%	53	$1K
83013		<1%	28	$979.25
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	53	$914.88
85651		<1%	464	$909.88
84403		<1%	58	$881.55
82150		<1%	214	$779.49
87563		<1%	54	$755.12
86255		<1%	79	$562.49
86696		<1%	51	$536.08
87340		<1%	97	$515.07
86803		<1%	67	$484.32
87086	Culture, bacterial; quantitative colony count, urine	<1%	104	$475.30
84550		<1%	193	$472.38
84466		<1%	53	$384.05
84153		<1%	36	$374.50
85610		<1%	147	$372.10
85730		<1%	105	$349.99
81000		<1%	192	$336.94
86141		<1%	47	$323.79
84436		<1%	533	$322.96
83970		<1%	13	$312.00
87350		<1%	36	$232.62
82670		<1%	14	$226.79
84479		<1%	496	$225.27
82784		<1%	38	$203.02
82248		<1%	63	$184.20
86705		<1%	27	$181.44
86038		<1%	25	$175.75
86592		<1%	78	$171.03
86707		<1%	25	$165.05
84100		<1%	59	$160.56
88342		<1%	16	$152.22
84270		<1%	12	$151.13
84154		<1%	14	$139.10
83690		<1%	42	$138.02
84443	Thyroid stimulating hormone (TSH)	<1%	42	$120.52
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	12	$116.28
86780		<1%	13	$107.80
80345		<1%	14	$100.23
86709		<1%	13	$72.05
84480		<1%	92	$57.68
82043		<1%	16	$47.04
88311		<1%	32	$44.92
82550		<1%	13	$44.41
86735		<1%	13	$43.94
82465		<1%	23	$27.72
85004		<1%	12	$20.82
84478		<1%	13	$3.35
83718		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.